Sandoz, the generic pharmaceuticals division of Novartis, is a worldwide leader in generics. With a history of more than 120 years, Sandoz is a trusted leader with a reputation for quality. Read More.
Report an Adverse Event
The safety of our products and the health and well-being of our patients are our highest priority. If you would like to report an adverse event involving a Sandoz medicine then please click the following link. Read More.
Sandoz registers all trials at www.clinicaltrial.gov.
UK/MKT/SDZ/14-0002, March 2014.
Sandoz UK has a portfolio of over 350 products. Our portfolio covers both blockbusters and niche products for all major therapeutic areas, in particular cardiovascular, gastrointestinal, anti-infectives/antivirals, central nervous system, pain, respiratory and many more. Read More.
Your feedback is valuable as we are committed to continuously improving our products, services and providing greater value to our patients, customers and others. If you have a question or comment that you would like to share with our team, please use the following link. Read More.
Sandoz was the first company to develop and market follow-on versions of highly complex biopharmaceuticals. Today, we are the global leader in this segment and have an industry-leading pipeline that will make essential biopharmaceuticals more affordable for all. Read More.
Nothing is more important than our people. Sandoz associates worldwide share a vision of improving patients' lives by providing access to quality, cost-effective medicines. If you share our vision then why not join us and begin your Sandoz career today. Read More.
Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to make medicines affordable and accessible to more than 90 percent of the world’s population. Learn more about our commitment to patients, doctors and healthcare professionals, as well as the communities in which we live and work.
Sandoz was the first company to develop and market follow-on versions of highly complex biopharmaceuticals. Today, we are the undisputed global leader in this segment and have an industry-leading pipeline that will make essential biopharmaceuticals more affordable for all.
As part of the Novartis group, we believe that superior quality is key to our long-term success. Our state-of-the-art technologies, decades of experience, and rigorous across-the-board quality standards all contribute to a product we are justly proud of: quality at an affordable price.